FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Minimally invasive prostate cancer treatment shows success in first patient

2.

Updates from the 2022 WHO classification of kidney epithelial tumors

3.

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

4.

Severe obesity associated with reduced prevalence of recommended cancer screenings

5.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot